Eur J Pharmacol 635:171176
Treat your research compounds with the respect they deserve
Can You Improve Your Natural GLP-1 Response
We excluded patients with cirrhotic liver, history of gall bladder, biliary disorders, pancreatic diseases, interrupted use of GLP-1RAs throughout the study period, and patients used other drugs with potential effects on the motility of biliary tracts such as cholecystokinin, motilin hormone, cholinomimetic agents like prostigmine, erythromycin, cisapride, cholystyramine, intravenous aminoacids, cholinergic agents like atropine, somatostatin, and progesterone, trimebutine, loperamide and ondansetron
Use the smaller barrels for better readability on draws under 0.10 mL
Description BPC-157 (Body Protection Compound-157, CAS 137525-51-0) is a synthetic 15-amino-acid pentadecapeptide derived from a sequence identified in human gastric juice, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val